For people with multiple sclerosis (MS) on Ocrevus (ocrelizumab) whose disease is well controlled after at least a year…
Articles by Marisa Wexler, MS
Most people with multiple sclerosis (MS) have persistently high levels of antibodies against Epstein-Barr virus (EBV), but these…
Although the total number of people living with multiple sclerosis (MS) has increased globally in recent decades due to…
A “molecular atlas” of disease that can predict illness years before symptoms appear is the goal of a massive new…
Long-term exposure to air pollution may increase the risk of developing multiple sclerosis (MS), while short-term exposure may worsen…
A test that measures a specific set of proteins in cerebrospinal fluid (CSF) — the liquid that surrounds the brain…
Fenebrutinib, Genentech’s investigational BTK inhibitor, was found to significantly reduce relapse rates compared with the approved therapy Aubagio…
A specific pattern of damage seen on MRI scans, called a paramagnetic rim lesion, is associated with a higher risk…
Treatment with the experimental nasal spray therapy foralumab reduced microglial activity in people with nonactive secondary progressive multiple sclerosis…
Having parents who have ever smoked cigarettes, or who smoked in the three months before pregnancy, is associated with a…
Myelin-making cells in some areas of the brain were more resistant to injury in a mouse model of myelin damage…
Following specific diets may help reduce inflammation in people with multiple sclerosis (MS), but more research is needed,…
A type of immune cell that has received little attention in multiple sclerosis (MS) research may play a key…
A three-year study of GA Depot, a monthly injection for primary progressive multiple sclerosis (PPMS), found that most patients…
A new study suggests that how certain immune cells respond to Mavenclad (cladribine) may help explain why…
Years before a diagnosis of multiple sclerosis (MS), people who later develop the disease have more doctor visits and…
Oligodendrocytes, the cells responsible for making myelin, are constantly being made throughout the brain and spinal cord, even when…
Treatment with the nasal spray therapy foralumab stabilized disability over six months in all 10 people with nonactive secondary…
When immune B-cells mistakenly recognize the body’s own nerve tissue, they can shut themselves down to prevent damage, but infection…
People whose biological mothers had diabetes during pregnancy are more likely to develop multiple sclerosis (MS) as adults, according…
A new machine learning tool can now help predict whether people newly diagnosed with multiple sclerosis (MS) will experience…
A history of the Epstein-Barr virus (EBV) appears to alter the immune systems of people with specific genetic traits,…
People with multiple sclerosis (MS) who have mild disability still experience several disease-related difficulties at work — challenges that…
A group of international experts has proposed a first-of-its-kind framework aimed at preventing multiple sclerosis (MS) from developing. Rather…
Inflammatory gut bacteria that carry proteins structurally similar to myelin, a protective layer surrounding nerve fibers that is damaged in…
Multiple sclerosis (MS) may follow two distinct biological paths that differ in how early and how quickly nerve damage…
The balance between two immune signaling molecules — CXCL13 and BAFF — may help identify the hard-to-treat inflammation in the…
The National Institute for Health and Care Excellence (NICE) in England is recommending natalizumab — sold as Tysabri and…
Quantum Biopharma has completed dosing in two toxicology studies requested by the U.S. Food and Drug Administration (FDA) that…
Throughout 2025, the team at Multiple Sclerosis News Today brought our readers the latest advances and updates in research related…